Ibuprofen Market Size, Share, Growth, Trends, and Global Industry Analysis: By Indication (Fever, Inflammation, Pain), By Route of Administration (Oral, Parenteral), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and others, and Region Forecast 2020-2031

Ibuprofen Market size was valued at US$ 6832 million in 2023 and poised to grow at a significant CAGR of 7.6% from 2024-2030. Rising adoption of an intravenous drug delivery mode for acute pain management owing to faster commencement of action as associated with the additional routes (oral and transdermal mode of administration) as well as the targeted property of drug delivery. IV Ibuprofen progresses the management in pain through less dependency on opioid painkilling medicine, which may lead to numerous complications of health including sedation, dizziness, and others. Caldolor (Cumberland Pharmaceuticals) is predominantly an injectable Ibuprofen drug accessible in the market; henceforth, it partakes enormous demand with slight competition.

However, prolonged processes for approval coupled with restricted approvals in certain countries are projected to restraint the market growth. Key players in the global market enhance their product portfolio and consumer base by adopting striking market strategies like collaborations, acquisitions, and technological innovations, among others. For instance, on Feb 04, 2015- Harbin Gloria Pharma will pay a considerable amount to acquire a maximum stake in Shanxi Powerdone, which makes chemical drugs and compound preparations.